Adial Pharmaceuticals's total assets for Q3 2025 were $5.66M, a decrease of -16.79% from the previous quarter. ADIL total liabilities were $1.15M for the fiscal quarter, a -4.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.